Warby Parker (NYSE:WRBY – Free Report) had its price objective increased by The Goldman Sachs Group from $20.00 to $26.00 in a research note published on Tuesday,Benzinga reports. The Goldman Sachs Group currently has a buy rating on the stock.
Other analysts also recently issued research reports about the company. Telsey Advisory Group raised their price objective on Warby Parker from $22.00 to $26.00 and gave the stock an “outperform” rating in a research note on Tuesday, November 19th. Piper Sandler raised their price objective on Warby Parker from $18.00 to $22.00 and gave the stock an “overweight” rating in a research note on Friday, November 8th. BTIG Research lifted their price target on Warby Parker from $18.00 to $20.00 and gave the company a “buy” rating in a research note on Friday, November 1st. Robert W. Baird lifted their price target on Warby Parker from $18.00 to $23.00 and gave the company an “outperform” rating in a research note on Friday, November 8th. Finally, Deutsche Bank Aktiengesellschaft raised Warby Parker from a “neutral” rating to a “buy” rating and lifted their price target for the company from $15.00 to $18.00 in a research note on Monday, October 21st. Four research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company’s stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $19.55.
Read Our Latest Report on Warby Parker
Warby Parker Trading Up 0.1 %
Insider Buying and Selling
In other Warby Parker news, CFO Steven Clive Miller sold 14,853 shares of the business’s stock in a transaction that occurred on Tuesday, December 3rd. The stock was sold at an average price of $22.61, for a total transaction of $335,826.33. Following the transaction, the chief financial officer now owns 189,146 shares of the company’s stock, valued at $4,276,591.06. The trade was a 7.28 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO Neil Harris Blumenthal sold 36,163 shares of the business’s stock in a transaction that occurred on Tuesday, December 3rd. The stock was sold at an average price of $22.61, for a total value of $817,645.43. Following the transaction, the chief executive officer now directly owns 12,177 shares in the company, valued at approximately $275,321.97. This trade represents a 74.81 % decrease in their position. The disclosure for this sale can be found here. 26.55% of the stock is currently owned by corporate insiders.
Hedge Funds Weigh In On Warby Parker
Institutional investors have recently bought and sold shares of the business. First Eagle Investment Management LLC acquired a new position in shares of Warby Parker in the second quarter valued at approximately $131,000. Choreo LLC acquired a new stake in Warby Parker during the second quarter worth approximately $167,000. AQR Capital Management LLC acquired a new stake in Warby Parker during the second quarter worth approximately $186,000. Thrivent Financial for Lutherans acquired a new stake in Warby Parker during the third quarter worth approximately $213,000. Finally, LVW Advisors LLC grew its position in Warby Parker by 27.9% during the third quarter. LVW Advisors LLC now owns 16,027 shares of the company’s stock worth $262,000 after buying an additional 3,500 shares in the last quarter. Institutional investors and hedge funds own 93.24% of the company’s stock.
About Warby Parker
Warby Parker Inc provides eyewear products in the United States and Canada. The company offers eyeglasses, sunglasses, light-responsive lenses, blue-light-filtering lenses, non-prescription lenses, and contact lenses. It also provides accessories, such as cases, lenses kit with anti-fog spray, pouches, and anti-fog lens spray through its retail stores, website, and mobile apps.
Further Reading
- Five stocks we like better than Warby Parker
- What Are Dividends? Buy the Best Dividend Stocks
- Survey Reveals: Which States Saw the Biggest Investment Gains in 2024?
- How to Invest in Blue Chip Stocks
- Amazon’s Healthcare Gamble: A New Era of Medical Disruption
- Insider Trades May Not Tell You What You Think
- Semiconductor Giant Synopsys Slides 14% — Time to Take Notice
Receive News & Ratings for Warby Parker Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Warby Parker and related companies with MarketBeat.com's FREE daily email newsletter.